Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: a case study

BMC Pediatrics

Joseph P Kitzmiller¹  Lindsey Korbel¹  Steven Salhanick²  Alvaro Coronado³  Maya Haasz³  Mathew George³ 

[1] College of Medicine, Ohio State University, 333 West 10th Avenue, Columbus, OH 43210, USA;Department of Emergency Medicine, Beth Israel Deaconess medical center, 330 Brookline Avenue, Boston, MA 02215, USA;Department of Pediatrics, St. Barnabas Hospital, 4432 3rd avenue, Bronx, NY 10457, USA

关键词: Quetiapine insufflation;    Medication abuse;    Tardive dyskinesia;   

Others  :  1144244
DOI  :  10.1186/1471-2431-13-187

 received in 2013-04-12, accepted in 2013-11-06,  发布年份 2013

【 摘 要 】

Background

Although the benefits of antipsychotic pharmacotherapy can be pronounced, many patients develop unwanted adverse effects including a variety of movement disorders. Compared with the traditional antipsychotics, the atypical antipsychotics have a decreased risk for associated movement disorders. Drug-induced movement disorders can occur, however, and the risk of adverse events can increase significantly when medications are abused.

Case presentation

We describe the case of a 13-year-old male who presented to an emergency department with acute movement disorders after nasal insufflation of crushed quetiapine. The patient was admitted and successfully treated for neuroleptic toxicity with intravenous antihistamine pharmacotherapy. His primary care provider and psychiatrist were notified of the abuse, quetiapine was discontinued, and the patient was discharged and referred to a drug and alcohol awareness and abuse program.

Conclusions

The abuse of quetiapine has unfortunately become more common. This unique case report of acute movement disorders following nasal insufflation of quetiapine highlights the need for heightened vigilance when prescribing quetiapine and for increased awareness and education regarding medication-abuse.

【 授权许可】

   
2013 George et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Fischer BA, Boggs DL: The role of antihistaminic effects in the misuse of quetiapine: a case report and review of the literature. Neurosci Biobehav Rev 2010, 34(4):555-558.
• [2]Paparrigopoulos T, Karaiskos D, Liappas J: Quetiapine: another drug with potential for misuse? A case report. J Clin Psychiatry 2008, 69(1):162-3.
• [3]Murphy D, Bailey K, Stone M, Wirshing WC: Addictive potential of quetiapine. Am J Psychiatry 2008, 165(7):918.
• [4]Reeves RR, Brister JC: Additional evidence of the abuse potential of quetiapine. South Med J 2007, 100(8):834-6.
• [5]Pinta ER, Taylor RE: Quetiapine addiction? Am J Psychiatry 2007, 164(1):174-75.
• [6]Morin AK: Possible intranasal quetiapine misuse. Am J Health Syst Pharm 2007, 64(7):723-5.
• [7]Waters BM, Joshi KG: Intravenous quetiapine-cocaine use (“Q-ball”). Am J Psychiatry 2007, 164(1):173-4.
• [8]Hussain MZ, Waheed W, Hussain S: Intravenous quetiapine abuse. Am J Psyhicatry 2005, 162:1755-1756.
• [9]Rizos E, Douzenis A, Gournellis R, et al.: Tardive Dyskinesia in a patient treated with quetiapine. World J Biol Psychiatry 2009, 10:54-57.
• [10]Ghaemi SN: Quetiapine-related tardive dyskinesia. Am J Psychiatr 2001, 158:1737.
• [11]Sharma V: Treatment-emergent tardive dyskinesia with quetiapine in mood disorders. J Clin Psychopharmacol 2003, 23:415-416.
• [12]Velayudhan L, Kirchner V: Quetiapine-induced myoclonus. Int Clin Psychopharmacol 2005, 20(2):119-20.
• [13]Strachan PM, Benoff BA: Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy 2006, 26:578-82.
• [14]Aggarwal A, Jiloha RC: Quetiapine induced myoclonus. Indian J Med Sci 2008, 62:422-3.
• [15]Desarkar P, Sinha VK: Quetiapine-induced acute dystonia and akathisia. Aust N Z J Psychiatry 2006, 40:607-8.
• [16]Bharadwaj R, Grover S: Parkinsonism and akathisia with quetiapine: three case reports. J Clin Psychiatry 2008, 69:1189-91.
• [17]Shah R, Grover S, Maheshwari U, Kate N, Malhotra N: Acute akathisia with quetiapine: a case report and review of the literature. Indian J Pharmacol 2010, 42:416-7.
• [18]Sansone RA, Sansone LA: Is seroquel developing an illicit reputation for misuse/abuse? Psychiatry 2010, 7:13-16.
• [19]Pierre JM, Shnayder I, Wirshing DA, et al.: Intranasal quetiapine abuse. Am J Psychiatr 2004, 161:1781.
• [20]Silver M, Factor SA: Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia. Parkinsonism Relat D 2013, 19(8):758-60.
• [21]Austin Bradford H: The environment and disease: association or causation? Proc R Soc Med 1965, 58:295-300.
• [22]Naranjo CA, Busto U, Sellers EM, et al.: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30:239-245.